BURROUGHS AMY L. (Chief Executive Officer) sold 4.8% of their position (14.58K shares) of TERNS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $681.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/17/2026ACC: 0001872564-26-000008
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-14.58K
Net shares
Net seller
$681.1K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
14.58K acquired · 29.17K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+14.58K
Price / share
$4.64
Trade value
$67.67K
% of position
5.0%
3/16/2026
288.98K→303.56K
Common Stock
Direct
Shares
−11.81K
Price / share
$46.57
Trade value
$550.08K
% of position
3.9%
3/16/2026
303.56K→291.75K
Common Stock
Direct
Shares
−2.77K
Price / share
$47.30
Trade value
$131.03K
% of position
0.9%
3/16/2026
291.75K→288.98K
Total
Net shares
+0.00
Net value
-$613.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | M · Option Exercise | +14.58K | $4.64 | $67.67K | 5.0% | 288.98K | 303.56K |
| Common Stock Direct | 3/16/2026 | S · Sale | −11.81K | $46.57 | $550.08K | 3.9% | 303.56K | 291.75K |
| Common Stock Direct | 3/16/2026 | S · Sale | −2.77K | $47.30 | $131.03K | 0.9% | 291.75K | 288.98K |
| Total | +0.00 | -$613.44K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14.58K shares
Shares
−14.58K
Strike price
4.64
Held after
955.53K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14.58K shares | 3/16/2026 | M · Option Exercise | −14.58K | 4.64 | — | 955.53K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned8.32K
Total
8.32K indirect8.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.32K | Indirect |
| Total | 8.32K | 8.32K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported